JANSSEN ONCOLOGY INC has a total of 27 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and computer technology are EMOTIONAL BRAIN BV, CHASE THERAPEUTICS CORP and EB IP LYBRIDO B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Jordan | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Philippines | 1 | |
#12 | Serbia | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Computer technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Auerbach Alan H | 15 |
#2 | Belldegrun Arie S | 15 |
#3 | Tran Namphuong | 10 |
#4 | De Bono Johann | 2 |
#5 | Namphuong Tran | 1 |
Publication | Filing date | Title |
---|---|---|
BR112020007090A2 | methods of treating prostate cancer by administering abiraterone acetate plus prednisone with androgen suppression therapy | |
US2014336157A1 | Methods and compositions for treating cancer |